Tailored CDMO And Clinical Supply Solutions For Your Most Complex Needs

Drug developers face rising complexity across formulation, manufacturing, packaging, and global clinical supply, making access to specialized, phase‑appropriate support more valuable than ever. This capabilities overview highlights an integrated service model designed to streamline programs from early development through clinical execution. Offerings span analytical method development, stability testing, and inhalation‑specific characterization, along with formulation design, spray drying, precision powder processing, and encapsulation supported by advanced containment systems for highly potent materials.

The matrix also details flexible clinical packaging and labeling, including blistering, bottling, device filling, and serialized carton‑level aggregation. End‑to‑end distribution capabilities support global site shipments, returns, and destruction, complemented by extensive ambient, refrigerated, frozen, and ultra‑cold storage capacity with safeguards for controlled substances. For programs entering the EU, access to Qualified Person services enables compliant batch certification and seamless cross‑border movement.

Altogether, the resource offers a clear view of how coordinated capabilities help teams reduce handoffs, strengthen compliance, and maintain momentum across complex development pipelines.